Commentary By Sandra D’Angelo, PGY-3
Breast cancer is the most common cancer diagnosed in women, second only to lung cancer as a leading cause of death from cancer. Experts state that approximately 210, 000 women will be diagnosed in 2006 …
Category: Systems
Clinical Correlations
More Breaking News for the Glitazones…
March 15, 2007
Coming right on the heels of the recent warning from the FDA about the risk of fractures and Rosiglitazone, the FDA announced on March 9th that pioglitazone (Actos) has also been linked to an increased occurrence of arm, hand, and foot fractures among …
When Should You Order a Serum Fructosamine Level for a Diabetic Patient?
March 14, 2007
Commentary By: Christopher Johnson, MSIV and Glenn Matfin, MD Clinical Associate Professor of Medicine, Divsion of Endocrinology
When was the last time you had a diabetic patient in clinic whose hemoglobin A1C was elevated, prompting you to modify their diabetic regimen? …
Does the Overuse of Macrolides Lead to Antibiotic Resistance?
March 12, 2007
Commentary By: Danise Schiliro, PGY-3
Although intuitively we always worry about creating drug resistance when using antibiotics, there is a surprising lack of well done studies that show a clear causal effect of antibiotic use on the development of subsequent drug resistance. A …
How Do You Approach A Patient with a Non-Ischemic Cardiomyopathy
March 7, 2007
A 26 year old woman developed uncontrolled hypertension peripartum 5 years prior to this presentation After diagnosis she was intermittently compliant with her medication although remained asymptomatic. She now presents with new onset congestive heart failure. On admission, she was in …
More Breaking News: Rosiglitazone Linked to Fractures
March 6, 2007
Commentary By: Cara Litvin PGY-3
The FDA recently informed physicians of a report issued by GlaxoSmithKline acknowledging that Avandia (rosiglitazone) has been linked to increased fractures in females (1). The report stems from a review of the safety data from ADOPT (A Diabetes …
Safety of Long-Acting Beta-Agonists in the Treatment of Asthma: Should they be used?
February 21, 2007
Commentary By: Sarah Huen, PGY-3 and David Chong, Director of Critical Care, Bellevue Hospital, Associate NYU Internal Medicine Residency Program Director
The role of long-acting b-agonists (LABAs) in the treatment of asthma continues to be controversial. Growing evidence that LABAs may cause an …
Should patients with Anemia and a Normal Ferritin Undergo Colonoscopy?
February 16, 2007
Commentary By: Joshua Olstein PGY-3
Second only to lung cancer, colon cancer claimed an estimated 55,000 lives in the United States in 2006. In an effort to reduce colon cancer morbidity and mortality, multiple screening tests have been developed to detect early disease among …